Browse all clinical trials

Sponsor Updatedsort icon
Phase III A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids Bristol-Myers Squibb 2009-05-20
Phase I Study of BMS-354825 in Children and Adolescents With Relapsed or Refractory Leukemia Bristol-Myers Squibb 2009-05-20
Phase III Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer National Cancer Institute (NCI) 2009-05-20
Phase II Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer Fudan University 2009-05-20
Phase I Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children Bristol-Myers Squibb 2009-05-20
Phase III Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML Bristol-Myers Squibb 2009-05-20
Phase III A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse Bristol-Myers Squibb 2009-05-20
Phase III A Primary Care Intervention for Weight Management National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-05-20
Phase IV Randomized Controlled Double Blind Trial of Short vs Long Acting Dihydrocodeine in Chronic Non-Malignant Pain Norwegian University of Science and Technology 2009-05-20
Computer-Assisted Self-Administration of Ethanol National Institute on Alcohol Abuse and Alcoholism (NIAAA) 2009-05-20
Phase I A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2) Bristol-Myers Squibb 2009-05-20
Phase I A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects Bristol-Myers Squibb 2009-05-20
Phase III Phase 3, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation Forest Laboratories 2009-05-20
Phase III Study of an Investigational Drug for the Prevention of Thrombosis-Related Events Following Knee Replacement Surgery Bristol-Myers Squibb 2009-05-20
Phase III Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Bristol-Myers Squibb 2009-05-20
Phase I Vaccine Therapy and GM-CSF in Treating Patients With Stage III or Stage IV Breast Cancer or Ovarian Cancer National Cancer Institute (NCI) 2009-05-20
Phase III Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer National Cancer Institute (NCI) 2009-05-20
Phase I Radiolabeled Monoclonal Antibody Therapy Combined With Total-Body Irradiation, Allogeneic Peripheral Stem Cell Transplantation, and Immunosuppression Therapy in Treating Older Patients Who Have Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome, or National Cancer Institute (NCI) 2009-05-20
Phase IV Mechanisms of Action of Acetaminophen University of Pennsylvania 2009-05-20
Phase I Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease National Cancer Institute (NCI) 2009-05-20
Phase III Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-Small Cell Lung Cancer National Cancer Institute (NCI) 2009-05-20
Phase III A Phase III Study of Dasatinib vs. Imatinib in Patients With Newly Diagnosed Chronic Phase CML Bristol-Myers Squibb 2009-05-20
Phase I BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies Bristol-Myers Squibb 2009-05-20
Phase I Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers Novartis Pharmaceuticals 2009-05-20
Linkage Analysis in Interstitial Cystitis National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-05-20